Pneumococcal conjugate second or third-dose vaccines (PCVc) in Western Pacific (WHO region)
Western Pacific (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc) was 34.0% in 2025. ◆ Volatile
Latest (2025)
34.0%
Change on year
unchanged
Rank
11th
of 11 groups
All-time high
34.0%
in 2024
All-time low
1.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Western Pacific (WHO region), 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Western Pacific (WHO region) is 34.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 277.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Western Pacific (WHO region) peaked at 34.0% in 2024 and was at its lowest, 1.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Western Pacific (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 1.0% | — |
| 2009 | 1.0% | +0.0% |
| 2010 | 1.0% | +0.0% |
| 2011 | 5.0% | +400.0% |
| 2012 | 4.0% | -20.0% |
| 2013 | 5.0% | +25.0% |
| 2014 | 7.0% | +40.0% |
| 2015 | 9.0% | +28.6% |
| 2016 | 11.0% | +22.2% |
| 2017 | 10.0% | -9.1% |
| 2018 | 12.0% | +20.0% |
| 2019 | 14.0% | +16.7% |
| 2020 | 16.0% | +14.3% |
| 2021 | 17.0% | +6.2% |
| 2022 | 21.0% | +23.5% |
| 2023 | 27.0% | +28.6% |
| 2024 | 34.0% | +25.9% |
| 2025 | 34.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.0% | 1.0% | 1.0% | 2 |
| 2010s | 7.8% | 1.0% | 14.0% | 10 |
| 2020s | 24.8% | 16.0% | 34.0% | 6 |
Countries ranked near Western Pacific (WHO region)
- 11 Turkmenistan 98.0% compare
- 11 El Salvador 98.0% compare
- 11 Portugal 98.0% compare
- 11 Costa Rica 98.0% compare
- 11 Saudi Arabia 98.0% compare
- 11 Mauritius 98.0% compare
More health data for Western Pacific (WHO region)
- Diphtheria - number of reported cases 428 (2025)
- Total tetanus - number of reported cases 5,464 (2025)
- Pertussis - number of reported cases 159,013 (2025)
- Measles - number of reported cases 78,782 (2025)
- Neonatal tetanus - number of reported cases 214 (2025)
- Thinness among children and adolescents, BMI-for-age < -2 standard 4.5% (2024)
- Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) 38.3% (2024)
- Under-five mortality rate 12.12 (2024)
- Overweight among children and adolescents, BMI-for-age > +1 standard 27.9% (2024)
- Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) 9.7% (2024)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Western Pacific (WHO region)?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Western Pacific (WHO region) was 34.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Western Pacific (WHO region)?
- The highest recorded value was 34.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Western Pacific (WHO region)?
- The lowest recorded value was 1.0% in 2008.
- How does Western Pacific (WHO region) rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Western Pacific (WHO region) ranks 11th out of 11 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Western Pacific (WHO region)?
- Over the last ten years it is up 277.8%. The long-run trend across the full record is volatile.
- Where does this Western Pacific (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).